Skip to content
Review Open access

Non-pharmacological interventions modulating immune response in Parkinson's Disease: where do we stand for future preventive approaches.

Jul 2026 · Neurochemistry International · Vol 199, pp. 106211 · 0 citations · 429 references
Medicine

TL;DR

Current evidence on non-pharmacological approaches such as dietary changes, physical activity, and gut microbiome regulation are examined, focusing on their potential to modulate both peripheral and central immune responses, thereby influencing the progression of Parkinson's disease.

Abstract

Parkinson's disease (PD) imposes a growing socioeconomic burden due to its increasing prevalence and lack of a cure. Existing treatment options primarily manage motor and nonmotor symptoms but do not halt or slow disease progression, underscoring the urgent need for more effective and preventative strategies. Growing evidence suggests a strong link between immune system dysfunction, chronic inflammation, and the early pathogenesis of Parkinson's disease, often occurring years before the onset of motor symptoms, thereby indicating a critical window for early intervention. In this review, we examine current evidence on non-pharmacological approaches such as dietary changes, physical activity, and gut microbiome regulation, focusing on their potential to modulate both peripheral and central immune responses, thereby influencing the progression of PD. Besides being complementary to standard pharmacological treatments, these approaches not only reduce systemic inflammation but may also help delay, prevent, or improve clinical management of PD by targeting and modulating its immunological foundations.

Read PDF

Similar papers

Review Open access Aug 2026

Non-pharmacological strategies for the management of Alzheimer's disease

The evidence on diverse non-pharmacological therapies for managing AD is synthesized and their practical implications for clinical care are discussed to generate a broader and more lasting impact on disease treatment.

Gunaro Lucas dos Santos de Oliveira, A. G. Bertollo · 0 citations
Review Jul 2026

Molecular Mechanisms and Therapeutic Strategies in Parkinson's Disease: From Pathogenic Signaling to Drug Development.

This review systematically summarizes the molecular mechanisms and biomarkers associated with PD, outlines current symptomatic treatments, and discusses emerging therapeutic candidates in clinical development, with particular emphasis on disease-modifying strategies.

Zhihui Shen, Jiaxin Cheng, Linlin Wang et al. · 0 citations
Review Jul 2026

Nutritional Intervention Strategies for Alzheimer's Disease from the Perspective of the Gut-Brain Axis

A systematic review of multiple nutritional intervention strategies based on gut microecology regulation, including probiotics, prebiotics, polyphenolic antioxidants, omega‑3 fatty acids, and fecal microbiota transplantation, aiming to provide references for subsequent research and translational applications in this fi...

Xinyue Miao · 0 citations
Review Open access Jul 2026

Advancements in non-pharmaceutical interventions for Alzheimer’s disease management: an update review

This review systematically synthesizes literature from the PubMed and Web of Science databases to evaluate the comparative efficacy of physical activity, dietary interventions, and cognitive stimulation therapy (CST), aiming to establish an evidence-based framework for optimized clinical implementation.

Jialin Chen, Ziyu Zhang · 0 citations
Review Aug 2026

Therapeutic landscape of Parkinson's disease: Recent advances in saponin-mediated interventions.

Overall, saponins represent a promising avenue for the development of novel neuroprotective and disease-modifying therapies for PD, and challenges such as poor bioavailability in natural sources and limited access to brain remain significant barriers to clinical translation.

Debasmita Tripathy, Shreya Sen Sarma, Deepak Kumar et al. · 0 citations
Open access Jul 2026

Therapeutic Strategies for Multiple Sclerosis: Approved and Investigational Treatments

DMTs along with innovative therapeutic interventions reaching clinical trial testing and further development are summarized, offering patients more favorable treatment onset and opportunities for improved neurological impairment.

Letong Chen · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.